8-K
Current Report
Protagenic Therapeutics, Inc.\new Filed Acc 0001170918-07-000738
Executive or director change · Code of ethics change
- Item 5.02 Departure or appointment of directors or officers
- Item 5.05 Amendment to or waiver of the code of ethics
From the SEC's structured data for this filing
Loading fm8k-082007.txt…